![](/img/cover-not-exists.png)
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Mateo, Joaquin, Porta, Nuria, Bianchini, Diletta, McGovern, Ursula, Elliott, Tony, Jones, Robert, Syndikus, Isabel, Ralph, Christy, Jain, Suneil, Varughese, Mohini, Parikh, Omi, Crabb, Simon, RobinsonJournal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30684-9
Date:
December, 2019
File:
PDF, 376 KB
2019